PEDIATRICS Vol. 72 No. 5 November 1983, pp. 748-749
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by BASS, J. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by BASS, J. W.

Use of Erythromycin in Pertussis Outbreaks

JAMES W. BASS MD1

1 Department of Pediatrics, Tripler Army Medical Center, Honolulu, HI 96819

To the Editor.—

With two outbreaks of pertussis recently observed and soon to be reported in Maryland (41 cases) and Hawaii (24 cases), it is appropriate that all means to curb spread of infection from individuals involved in these outbreaks be properly utilized. In this regard, I would like to take issue with a recommendation in the current Red Book.1 Certainly, erythromycin is presently the drug of choice for pertussis but the recommended duration of treatment of seven to ten days is inadequate.




This article has been cited by other articles:


Home page
 PediatricsHome page
S. A. Halperin, R. Bortolussi, J. M. Langley, B. Miller, and B. J. Eastwood
Seven Days of Erythromycin Estolate Is as Effective as Fourteen Days for the Treatment of Bordetella pertussis Infections
Pediatrics, July 1, 1997; 100(1): 65 - 71.
[Abstract] [Full Text] [PDF]